Modified- versus immediate-release tofacitinib in Japanese rheumatoid arthritis patients: A randomized, phase III, non-inferiority study
Tanaka Y et al. Rheumatology (Oxford) 2018: key250. doi: 10.1093/rheumatology/key250
Please follow the link below to view this article in full on a third-party website. Note that a subscription or payment may be required.